Cargando…
Hematopoietic Stem Cell Gene Therapy for Brain Metastases Using Myeloid Cell–Specific Gene Promoters
BACKGROUND: Brain metastases (BrM) develop in 20–40% of cancer patients and represent an unmet clinical need. Limited access of drugs into the brain because of the blood-brain barrier is at least partially responsible for therapeutic failure, necessitating improved drug delivery systems. METHODS: Gr...
Autores principales: | Andreou, Tereza, Rippaus, Nora, Wronski, Krzysztof, Williams, Jennifer, Taggart, David, Cherqui, Stephanie, Sunderland, Ashley, Kartika, Yolanda D, Egnuni, Teklu, Brownlie, Rebecca J, Mathew, Ryan K, Holmen, Sheri L, Fife, Christopher, Droop, Alastair, Lorger, Mihaela |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7301153/ https://www.ncbi.nlm.nih.gov/pubmed/31501884 http://dx.doi.org/10.1093/jnci/djz181 |
Ejemplares similares
-
Biglycan and reduced glycolysis are associated with breast cancer cell dormancy in the brain
por: Sunderland, Ashley, et al.
Publicado: (2023) -
Metastatic site-specific polarization of macrophages in intracranial breast cancer metastases
por: Rippaus, Nora, et al.
Publicado: (2016) -
Immune Checkpoint Blockade – How Does It Work in Brain Metastases?
por: Lorger, Mihaela, et al.
Publicado: (2019) -
Hematopoietic stem cell gene therapy targeting TGFβ enhances the efficacy of irradiation therapy in a preclinical glioblastoma model
por: Andreou, Tereza, et al.
Publicado: (2021) -
Coordination of asparagine uptake and asparagine synthetase expression modulates CD8(+) T cell activation
por: Hope, Helen Carrasco, et al.
Publicado: (2021)